Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024JCO Precision OncologyOpen Access

Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

GVGillian VandekerkhoveVGVeda N. GiriSHSusan Halabi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vandekerkhove et al. (2024) studied this question.

synapsesocial.com/papers/68e761c9b6db6435876d7ba3https://doi.org/10.1200/po.23.00654
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Role of Genomic Scores in the Management of Prostate Cancer Patients: A Comprehensive Narrative Review2025 · 8 citations
  2. 2Implementing comprehensive population-wide genomic testing in metastatic prostate cancer (mPCa): A real-world Canadian cohort study.2026
  3. 3Tissue-Based Genomic Testing in Prostate Cancer: 10-Year Analysis of National Trends on the Use of Prolaris, Decipher, ProMark, and Oncotype DX2024 · 46 citations
  4. 4Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients2025 · 1 citations
  5. 5Identifying and Characterizing the Germinal Genetic Landscape of Men with Prostate Cancer—A Real‐Life Retrospective Multi‐Centered Study2025